As biotech stocks experience a broad correction, the analyst cited in today’s article sees “a number of compelling values” in the space. In particular, he believes that select products from three biotech companies could top first-quarter expectations. For more, CLICK HERE.
Looking For Wins In The Biotech Space
- by RobH
